Get startedLog in
    Picture of Chordate Medical Holding AB (publ) logo

    CMH — Chordate Medical Holding AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Chordate: Clinical Evaluation Of Treatment For Rhinitis In Public Hospitals In Saudi Arabia Now Approved

    Picture of Chordate Medical Holding AB (publ) logoChordate Medical Holding AB (publ)
    29/06/2021 09:48
    June 29 (Reuters) - Chordate Medical Holding publ AB
 CMHM.NGM :
    * CLINICAL EVALUATION OF CHORDATES K.O.S TREATMENT FOR
RHINITIS IN
PUBLIC HOSPITALS IN SAUDI ARABIA NOW APPROVED
    * TREATMENT HAS NOW BEEN APPROVED IN A CLINICAL EVALUATION
AT
THREE MAJOR HOSPITALS IN SAUDI ARABIA, ORDERED BY MINISTRY OF
HEALTH IN COUNTRY
    * THIS MEANS THAT COST OF TREATMENT WILL AUTOMATICALLY BE
COVERED
BY PUBLIC HEALTH INSURANCE AND CHORDATE'S DISTRIBUTOR WILL BE
GIVEN ACCESS TO OFFER TREATMENT TO COUNTRY'S PUBLIC HOSPITALS

Source text for Eikon:  ID:nBQN4VR6g 
Further company coverage:  CMHM.NGM 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Chordate Medical Holding AB (publ)

    See all news